Pforte Helmholtz Munich Banner

We are Helmholtz Munich.

We discover breakthrough solutions for better health in a rapidly changing world.

We discover breakthrough solutions for better health in a rapidly changing world.

Our Vision & Mission

Our world is constantly changing. This impacts our health. Many widespread diseases such as diabetes, allergies and lung diseases are on the rise. Climate change is causing new diseases to emerge.

We develop solutions for a healthier future. Our cutting-edge research is the springboard for medical innovations. Together with our partners, we accelerate the transfer from ideas to applications, from labs to startups, from science to society.

Our Management

Porträt Martin Hrabe de Angelis
Querformat
Background: Office / Indoorplant
Prof. Dr. Dr. h.c. mult. Martin Hrabě de Angelis

Member and Spokesperson of the Executive Board (acting)

View profile
Michael Frieser
Dr. Michael Frieser

Administrative Managing Director

View profile

Helmholtz Munich in Numbers

2555
Employees
90
Nations
1371
Publications in 2024
422
PhD students
31
Spin-Offs
66
ERC Grants

Member of the Helmholtz Association

  • We belong to the largest research network in Germany.
  • We receive long-term core funding for our research projects.
  • We offer our scientists an excellent infrastructure.

Our Locations

How We Work

Awards & Grants

See all
Akademiepreis für Fabian Theis

AI, Awards & Grants, Computational Health, ICB,

Fabian Theis Receives Akademiepreis of the Berlin-Brandenburg Academy of Sciences and Humanities

Prof. Fabian Theis has been awarded the Akademiepreis of the Berlin-Brandenburg Academy of Sciences and Humanities. The Academy honors his pioneering work in computational biomedicine and the development of novel methods for biomedical data analysis.…

Marcus Conrad Elected to the Leopoldina

Awards & Grants, Molecular Targets and Therapeutics, MCD,

Marcus Conrad Elected to the Leopoldina

Prof. Marcus Conrad has been elected a member of the German National Academy of Sciences Leopoldina. With this prestigious scientific honor, the Academy recognizes his outstanding contributions to the study of regulated cell death and its…

Portrait Stephan Herzig, Querformat;

Awards & Grants, Diabetes, IDC,

Stephan Herzig Receives the 2026 Friedrich Arnold Gries Award from the DDG

Prof. Stephan Herzig has been awarded the 2026 Friedrich Arnold Gries Award by the German Diabetes Association (DDG). The award recognizes his outstanding scientific work on “Molecular characterization and therapeutic exploitation of…

Michele Solimena

Awards & Grants, Diabetes, IPI,

Michele Solimena Honored With the 2026 Paul Langerhans Medal of the DDG

Prof. Michele Solimena received the Paul Langerhans Medal, the highest award of the German Diabetes Society (DDG), on May 15, 2026. The prize recognizes his outstanding lifetime scientific achievements in the field of diabetes research. The…

Screenshot pancreas für research area "type 1 diabetes pathology" (Teresa Rodgriguez-Calvo)

Awards & Grants, Diabetes, IDF,

New Funding Supports Research into Causes and Treatment of Type 1 Diabetes

Dr. Teresa Rodriguez-Calvo from Helmholtz Munich has been awarded two prestigious grants from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization. The funding will support two innovative projects at the…

Porträt Marcus Conrad_KI_Erweiterung für Typo3

Awards & Grants, Molecular Targets and Therapeutics, MCD,

Marcus Conrad Receives Fondation ARC Léopold Griffuel Award

Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich, has been honored with the 54th Fondation ARC Léopold Griffuel Award for Translational and Clinical Research. The award recognizes his pioneering…

Portrait Anette Gabriele Ziegler, Querformat;

Awards & Grants, Diabetes, IDF,

Anette-Gabriele Ziegler Receives Claude Bernard Prize for Diabetes Research

Prof. Anette-Gabriele Ziegler from Helmholtz Munich has been named the recipient of the 58th Claude Bernard Prize, the highest honor awarded by the European Association for the Study of Diabetes (EASD). The prize recognizes her outstanding leadership…

Mitarbeiterin-/PI-Foto Antje Körner

Awards & Grants, Diabetes, HI-MAG,

Antje Körner Elected to the Saxon Academy of Sciences and Humanities in Leipzig

Physician and researcher Prof. Antje Körner has been elected as a new member of the Saxon Academy of Sciences and Humanities in Leipzig. On April 10, 2026, she was officially admitted to the Academy’s Mathematical and Natural Sciences Class during…

Porträt Marcus Conrad
Hochformat
Background: HDC Indoor

Awards & Grants, Molecular Targets and Therapeutics, MCD,

Marcus Conrad Receives German Cancer Award 2026

Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich was awarded the German Cancer Award 2026 in the category “Experimental Research”, together with Prof. José Pedro Friedmann Angeli of the University of…

Professor Timo Müller

Awards & Grants, Diabetes, IDO,

Timo Müller Receives the ADA 2026 Outstanding Scientific Achievement Award

The American Diabetes Association (ADA) has announced the recipients of this year's National Scientific and Health Care Achievement Awards. Among this year’s awardees is Prof. Timo Müller, Director of the Institute for Diabetes and Obesity (IDO) at…

Fabian Theis bei Eröffnung des Google AI Centers Berlin

AI, Awards & Grants, Computational Health, ICB,

Google Opens AI Center in Berlin and Supports AI Projects by Fabian Theis

On March 5, Google opened its first German AI Center in Berlin. The event was attended by representatives from politics, business, and science, including Federal Research Minister Dorothee Bär, Federal Digital Minister Karsten Wildberger, Berlin's…

NAKO und BABYDIAB Proben

Awards & Grants, Diabetes, IDF, Environmental Health, EPI,

Helmholtz Munich Secures Funding to Investigate Early-Stage Type 1 Diabetes in Adults

Helmholtz Munich has been awarded a prestigious grant of up to 900 000 US Dollar from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization. The funding will support the research into early-stage T1D in adults,…

DNA Double Helix with Mutation

Awards & Grants, Computational Health, ING,

Arcangela Iuso Receives the Eva Luise Köhler Research Award

Dr. Arcangela Iuso from the Institute of Neurogenomics at Helmholtz Munich was awarded the Eva Luise Köhler Research Award. The foundation thus honors a highly innovative research project on RNA base editing for a rare neurodegenerative disease.

Kidney Picture

Awards & Grants, Diabetes, IDM,

Anja Schork Receives “Junior Faculty Award 2025”

The journal Metabolism honors Dr. Anja Schork, who works at the Institute for Diabetes Research and Metabolic Diseases at Helmholtz Munich at the University of Tübingen and at the German Center for Diabetes Research (DZD), with the Junior Faculty…

Sandra Hummel 1

Awards & Grants, Diabetes, IDF,

Sandra Hummel Awarded the Dr. Heinz Bürger-Büsing Prize

Prof. Sandra Hummel, lead scientist of the research area “Lifestyle, Obesity, and Epigenetic Programming in Type 1 and Gestational Diabetes” at the Institute of Diabetes Research at Helmholtz Munich, has been awarded the Dr. Heinz Bürger-Büsing…

Our Organization

How is Helmholtz Munich funded?

Helmholtz Munich is a research institution owned by the Federal Government of Germany and the Free State of Bavaria which finance the center in a ratio of 90:10. In 2020, the funding amounted to 271.5 million euros. Addiotional third-party funding resulted in a total budget of 331,6 million euros in 2020.

How does Helmholtz Munich develop its research goals?

The centers of the Helmholtz Association are divided into six research fields:

  • Health
  • Energy
  • Earth and Environment
  • Aeronautics, Space and Transport
  • Information
  • Matter

For each research area, scientists develop research programs that are evaluated by international experts. This evaluation forms the basis for the program-oriented funding of Helmholtz research. Helmholtz Munich is fully anchored in the research field Health. For the current period our research is orientated towards the five topics of the program-oriented funding "Environmental and Metabolic Health" (ENABLE). This program provides the strategic research framework for Helmholtz Munich for the next seven years.

Helmholtz Munich is also part of Helmholtz Health. Together with five other Helmholtz Health Centers, we develop solutions for a healthier society in a network of cutting-edge biomedical research that is unique in Europe. Our mission is to translate research results as quickly as possible into advances for our society, our healthcare system and the economy. In order to continuously expand the transfer portfolio, to further increase the speed of transfer and to make essential contributions more effectively, Helmholtz Health is jointly pursuing a seven-point charter across the centers.

Supervisory Board

The Supervisory Board monitors the legality, expediency and economic efficiency of the work of the Board of Directors. It decides on the general research objectives, important research policy and financial matters, and the principles for performance review. The Supervisory Board currently has eight members. Of these, the shareholders (Federal Republic of Germany represented by the Federal Ministry of Research, Technology and Space, Free State of Bavaria represented by the Bavarian State Ministry of Finance and Home Affairs) delegate five members. In addition, there are three further members from the Saxon State Ministry of Science, Culture and Tourism and representatives of science and business.

Chairman: MinDir Thomas Romes

Board of Directors

The Board of Directors acts in accordance with the law, the Articles of Association, the Rules of Procedure and the instructions of the Shareholders' Meeting and the Supervisory Board. It shall cooperate with the other bodies of the Center.  

Member and Spokesperson of the Executive Board (acting): Prof. Dr. Dr. h.c. mult. Martin Hrabě de Angelis
Administrative Managing Director: Dr. Michael Frieser

Management Committee

The Management Committee advises the Board of Directors and makes recommendations on upcoming decisions on important matters, those of a fundamental nature and those of significant financial importance. Members of the Management Committee are scientific and administrative executives.

Chairman: Prof. Dr. Dr. h.c. mult. Martin Hrabě De Angelis 

Scientific Advisory Board

The Scientific Advisory Board advises the Supervisory Board and the Board of Directors. It is also responsible for evaluating the work of Helmholtz Munich. At present, eleven external scientists belong to the scientific advisory board.

Chairman: Prof. W. Langhans

Works Council

The works council is the elected representative body of the Helmholtz Munich employees and represents their interests vis-à-vis the Board of Directors.

Contact: betriebsratspam prevention@helmholtz-munich.de

Organization Chart

Please find our Organization Chart here.

Building a better world?

Join our team.